Web5 jun. 2024 · CNN — The US Food and Drug Administration has approved an injectable diabetes drug for long-term weight control. “This under-the-skin injection is the first approved drug for chronic... Web21 apr. 2024 · In 2024, the FDA approved three products—PRETOMANID, Ga 68 DOTATOC, and ZOLGENSMA® (onasemnogene abeparvovec-xioi)—in which an externally controlled trial provided the evidence needed to meet the “ substantial evidence ” standard. In this article, we examine three recent and important cases of RWE use in establishing …

FDA approves Gemtesa for overactive bladder - Healio

Web1 dag geleden · The new year always brings hope, but this January that hope was palpable for the over 50 million people with Alzheimer’s Disease (AD) worldwide, their families, friends, and clinicians when the ... cinepolis jojutla horario

What to Know About Ozempic, Wegovy and the New Weight-Loss …

Web1 dag geleden · As part of a $1 billion deal forged in 2024, Biogen has exercised the option to license a treatment candidate for Alzheimer’s disease developed by the US biotech company Denali Therapeutics. The engineered antibody drug is designed to cross into the brain and break down harmful plaques better than approved antibodies can. Web17 nov. 2024 · These include nintedanib (Ofev®) and pirfenidone (Esbriet®). These medications are called anti-fibrotic agents, meaning that they have shown in clinical trials to slow down the rate of fibrosis or scarring in the lungs. These drugs are approved for patients with mild, moderate and severe IPF. Web11 feb. 2024 · Brexanolone (sold under the brand name Zulresso) was approved by the FDA in March 2024. A derivative of allopregnanolone (a naturally produced steroid), it’s a new type of antidepressant. It appears to begin working within hours. Brexanolone is the first drug to have been scientifically shown to treat postpartum depression (PPD). cinepolis jojutla hoy